269 related articles for article (PubMed ID: 25348279)
1. Chronic inflammation, lymphangiogenesis, and effect of an anti-VEGFR therapy in a mouse model and in human patients with aspiration pneumonia.
Nihei M; Okazaki T; Ebihara S; Kobayashi M; Niu K; Gui P; Tamai T; Nukiwa T; Yamaya M; Kikuchi T; Nagatomi R; Ebihara T; Ichinose M
J Pathol; 2015 Mar; 235(4):632-45. PubMed ID: 25348279
[TBL] [Abstract][Full Text] [Related]
2. Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease.
Lee HS; Hos D; Blanco T; Bock F; Reyes NJ; Mathew R; Cursiefen C; Dana R; Saban DR
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3140-8. PubMed ID: 26024097
[TBL] [Abstract][Full Text] [Related]
3. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
4. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody.
Pytowski B; Goldman J; Persaud K; Wu Y; Witte L; Hicklin DJ; Skobe M; Boardman KC; Swartz MA
J Natl Cancer Inst; 2005 Jan; 97(1):14-21. PubMed ID: 15632376
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of lymphatic proliferation by the selective VEGFR-3 inhibitor SAR131675 ameliorates diabetic nephropathy in db/db mice.
Hwang SD; Song JH; Kim Y; Lim JH; Kim MY; Kim EN; Hong YA; Chung S; Choi BS; Kim YS; Park CW
Cell Death Dis; 2019 Mar; 10(3):219. PubMed ID: 30833548
[TBL] [Abstract][Full Text] [Related]
6. Platelet interaction with lymphatics aggravates intestinal inflammation by suppressing lymphangiogenesis.
Sato H; Higashiyama M; Hozumi H; Sato S; Furuhashi H; Takajo T; Maruta K; Yasutake Y; Narimatsu K; Yoshikawa K; Kurihara C; Okada Y; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Hokari R
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G276-85. PubMed ID: 27313177
[TBL] [Abstract][Full Text] [Related]
7. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
[TBL] [Abstract][Full Text] [Related]
8. Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis.
Krebs R; Tikkanen JM; Ropponen JO; Jeltsch M; Jokinen JJ; Ylä-Herttuala S; Nykänen AI; Lemström KB
Am J Pathol; 2012 Nov; 181(5):1607-20. PubMed ID: 22959907
[TBL] [Abstract][Full Text] [Related]
9. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
[TBL] [Abstract][Full Text] [Related]
10. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
Whitehurst B; Flister MJ; Bagaitkar J; Volk L; Bivens CM; Pickett B; Castro-Rivera E; Brekken RA; Gerard RD; Ran S
Int J Cancer; 2007 Nov; 121(10):2181-91. PubMed ID: 17597103
[TBL] [Abstract][Full Text] [Related]
11. Preferential lymphatic growth in bronchus-associated lymphoid tissue in sustained lung inflammation.
Baluk P; Adams A; Phillips K; Feng J; Hong YK; Brown MB; McDonald DM
Am J Pathol; 2014 May; 184(5):1577-92. PubMed ID: 24631179
[TBL] [Abstract][Full Text] [Related]
12. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
[TBL] [Abstract][Full Text] [Related]
13. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
14. Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis.
Kajiya K; Sawane M; Huggenberger R; Detmar M
J Invest Dermatol; 2009 May; 129(5):1292-8. PubMed ID: 19005491
[TBL] [Abstract][Full Text] [Related]
15. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
Lee JY; Hong SH; Shin M; Heo HR; Jang IH
Biochem Biophys Res Commun; 2016 Sep; 478(2):733-8. PubMed ID: 27507214
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg1 enhances lymphatic transport of intrapulmonary silica via VEGF-C/VEGFR-3 signaling in silicotic rats.
Yu J; Mao L; Guan L; Zhang Y; Zhao J
Biochem Biophys Res Commun; 2016 Mar; 472(1):182-8. PubMed ID: 26920056
[TBL] [Abstract][Full Text] [Related]
17. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function.
Hagura A; Asai J; Maruyama K; Takenaka H; Kinoshita S; Katoh N
J Dermatol Sci; 2014 Feb; 73(2):135-41. PubMed ID: 24252749
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor c/vascular endothelial growth factor receptor 3 signaling regulates chemokine gradients and lymphocyte migration from tissues to lymphatics.
Iwami D; Brinkman CC; Bromberg JS
Transplantation; 2015 Apr; 99(4):668-77. PubMed ID: 25606800
[TBL] [Abstract][Full Text] [Related]
19. VEGFR3 tyrosine kinase inhibition aggravates cisplatin nephrotoxicity.
Black LM; Farrell ER; Barwinska D; Osis G; Zmijewska AA; Traylor AM; Esman SK; Bolisetty S; Whipple G; Kamocka MM; Winfree S; Spangler DR; Khan S; Zarjou A; El-Achkar TM; Agarwal A
Am J Physiol Renal Physiol; 2021 Dec; 321(6):F675-F688. PubMed ID: 34658261
[TBL] [Abstract][Full Text] [Related]
20. Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase.
Matsui J; Funahashi Y; Uenaka T; Watanabe T; Tsuruoka A; Asada M
Clin Cancer Res; 2008 Sep; 14(17):5459-65. PubMed ID: 18765537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
